EP2889054B1 - Phototherapeutic device and phototherapeutic method - Google Patents

Phototherapeutic device and phototherapeutic method Download PDF

Info

Publication number
EP2889054B1
EP2889054B1 EP14195822.3A EP14195822A EP2889054B1 EP 2889054 B1 EP2889054 B1 EP 2889054B1 EP 14195822 A EP14195822 A EP 14195822A EP 2889054 B1 EP2889054 B1 EP 2889054B1
Authority
EP
European Patent Office
Prior art keywords
light
skin
emitting device
device units
condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP14195822.3A
Other languages
German (de)
French (fr)
Other versions
EP2889054A1 (en
Inventor
Kaori Ajiki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Intellectual Property Management Co Ltd
Original Assignee
Panasonic Intellectual Property Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panasonic Intellectual Property Management Co Ltd filed Critical Panasonic Intellectual Property Management Co Ltd
Publication of EP2889054A1 publication Critical patent/EP2889054A1/en
Application granted granted Critical
Publication of EP2889054B1 publication Critical patent/EP2889054B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0616Skin treatment other than tanning
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00863Fluid flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0626Monitoring, verifying, controlling systems and methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645Applicators worn by the patient
    • A61N2005/0647Applicators worn by the patient the applicator adapted to be worn on the head
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0651Diodes
    • A61N2005/0652Arrays of diodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659Radiation therapy using light characterised by the wavelength of light used infrared
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light
    • A61N2005/0663Coloured light

Definitions

  • the present disclosure relates to a phototherapeutic device and a phototherapeutic method.
  • a cosmetic device that irradiates the skin with light guided from a lens or an optical facial beautifying mask (see Japanese Unexamined Patent Application Publication No. 2005-27702 ) including a light source unit that irradiates the face with light having different hues through a mask have been disclosed.
  • WO 2012/011042 A2 relates to an apparatus for bio-stimulating phototherapy.
  • US 2013/066404 A1 relates to a light therapy platform system.
  • US 2005/0177093 A1 relates to a tissue inflammation therapy and monitoring device.
  • KR 10-0963687 B1 relates to a massage machine.
  • US 2007/129776 A1 relates to an external wearable light therapy treatment system.
  • One non-limiting and exemplary embodiment provides a phototherapeutic device according to claim 1 that can more effectively rejuvenate the skin.
  • a phototherapeutic cosmetic method is defined in claim 6.
  • the techniques disclosed here feature a phototherapeutic device as defined in claim 1.
  • a phototherapeutic device disclosed herein can more effectively rejuvenate the skin.
  • Cosmetic devices used to rejuvenate the skin by irradiating the skin with light have been developed (see, for example, Japanese Unexamined Patent Application Publication Nos. 2013-154229 and 2005-27702 ).
  • phototherapeutic devices have been developed (see, for example, Japanese Unexamined Patent Application Publication Nos. 2013-154229 and 2005-27702 ).
  • rejuvenation of the skin is a concept including, for example, improvement of blood circulation, activation of fibroblast, improvement of lymphatic circulation, whitening, suppression of occurrence of active oxygen, expansion of capillaries, acceleration of metabolism, enhancement of tissue regeneration capability, and muscle relaxant.
  • a phototherapeutic device described in Japanese Unexamined Patent Application Publication No. 2013-154229 has a light emission port, through which light is emitted, at an end of a hand-held cylindrical body.
  • a phototherapeutic device described in Japanese Unexamined Patent Application Publication No. 2005-27702 includes a large number of light emitting diodes (LEDs) disposed on a face sheet that covers the entire face.
  • LEDs light emitting diodes
  • the user applies the light emission port of the phototherapeutic device according to Japanese Unexamined Patent Application Publication No. 2013-154229 to a portion of the skin that the user desires to rejuvenate. Instead, the user covers the entirety of his/her face with the face sheet described in Japanese Unexamined Patent Application Publication No. 2005-27702 .
  • existing technologies can rejuvenate the skin and improve the skin conditions.
  • the intensity of light (irradiance and irradiation time) with which the phototherapeutic device irradiates the skin differs depending on the conditions of the skin including the thickness of discoloration, the degree of darkening, or the degree of activation of fibroblast. For example, a portion having thicker discoloration requires an irradiation with intenser light. On the other hand, an excessive irradiation of a portion of the skin that has fully been rejuvenated with light is not desirable. Thus, desirably, each portion of the skin is irradiated with light having an appropriate intensity that is neither too low nor too high.
  • the skin conditions are usually uneven and thus appropriately irradiating the entirety of the skin with light is difficult. Moreover, even in the case where each portion is individually irradiated with light, appropriately determining which portion of the skin is to be irradiated with light of how much intensity or for how long is difficult. In other words, existing technologies have difficulty in effectively rejuvenating the skin.
  • a phototherapeutic device of the disclosure is defined in claim 1.
  • the phototherapeutic device of the disclosure can more effectively rejuvenate the skin.
  • a first embodiment of the disclosure is an example of a basic form of the disclosure.
  • Fig. 1 illustrates an example of the configuration of a phototherapeutic device 100 according to this embodiment.
  • the phototherapeutic device 100 includes a sheet member 210, first to Mth skin-condition sensors 220 1 to 220 M , and first to Nth light-emitting device units 230 1 to 230 N .
  • the sheet member 210 is a member that can be attached to the skin.
  • the first to Mth skin-condition sensors 220 1 to 220 M are disposed in the sheet member 210 at different positions of the sheet member 210. Each of the first to Mth skin-condition sensors 220 1 to 220 M detects the conditions of a portion of the skin adjacent to the skin-condition sensor.
  • the first to Nth light-emitting device units 230 1 to 230 N are disposed at positions on the sheet member 210 corresponding to the positions of the respective first to Mth skin-condition sensors 220 1 to 220 M .
  • the first to Nth light-emitting device units 230 1 to 230 N operate in accordance with information related to the condition detected by the corresponding skin-condition sensors.
  • Each of the light-emitting device units 230 1 to 230 N includes multiple light-emitting devices that emit light having different wavelengths.
  • Each of the light-emitting device units 230 1 to 230 N may reduce or stop light emission when the degree to which the information detected by the corresponding skin-condition sensor has changed after the start of light emission has arrived at a predetermined threshold.
  • the phototherapeutic device 100 can irradiate each portion of the skin with light appropriate for the conditions of the portion, the skin can be effectively rejuvenated.
  • the phototherapeutic device 100 may have only one skin-condition sensor on the sheet member 210 instead of multiple skin-condition sensors.
  • the phototherapeutic device 100 may have only one light-emitting device unit on the sheet member 210 instead of multiple light-emitting device units.
  • a second embodiment of the disclosure is an example of a specific form when the disclosure is applied to a face sheet that covers the entire face.
  • Figs. 2A and 2B illustrate an example of the appearance of the phototherapeutic device 100 according to the embodiment.
  • Fig. 2A illustrates the appearance of the phototherapeutic device 100 when viewed from the side.
  • Fig. 2B illustrates the appearance of the phototherapeutic device 100 when viewed from the front.
  • the phototherapeutic device 100 includes a sheet device 200 and a control unit 300.
  • the sheet device 200 is a device having a three-dimensional shape that covers the face, both ears, the submandibular portion (these portions are collectively called the "face", as appropriate below) and the surface of the neck.
  • the base material of the sheet device 200 is a sheet member having elasticity and flexibility. Examples usable as the base material include a sheet member formed of a cured product of an energy-ray curable composition containing an acryloyl group-terminated urethane polymer and an acrylic monomer (see Japanese Unexamined Patent Application Publication No. 2013-168575 ).
  • the sheet device 200 has slits shaped so as to correspond to the shape of the closed eyes and openings shaped so as to correspond to the nostrils. Specifically, compared to typical face sheets, the sheet device 200 has a characteristic shape that covers the neck portion in addition to the upper eyelid, the lower eyelid, the lips, the ears, and the submandibular portion.
  • the sheet device 200 When placed at a predetermined portion of the face, the sheet device 200 can keep closely adhering to the skin surface of the entire face with the effect of the surface tension.
  • a biocompatible adhesive such as spirit gum, a silicone adhesive, or a latex adhesive may additionally be used. It is desirable that the sheet device 200 can be selected from among multiple sizes in accordance with various sizes of the face.
  • multiple skin-condition sensors and multiple light-emitting device units are disposed on the surface of the sheet member serving as the sheet device 200 on the side on which the sheet member closely adheres to the face.
  • the configuration of the sheet device 200 on which the multiple skin-condition sensors and the multiple light-emitting device units are arranged will be described in detail below.
  • the control unit 300 is a unit protected by a housing made of a material such as plastics.
  • the control unit 300 is connected to the sheet device 200 using a cable 400.
  • the control unit 300 is connected to each of the first to Mth skin-condition sensors 220 1 to 220 M of the sheet device 200.
  • the control unit 300 is connected to each of the first to Nth light-emitting device units 230 1 to 230 N of the sheet device 200. It is desirable that the cable 400 have such a length that the control unit 300 can be held in a pocket of the user's cloth.
  • the sheet device 200 and the control unit 300 be attachable to and detachable from each other using a connector 401 and the cable 400. This configuration enables replacement of the sheet device 200 with a new sheet device every time the user uses it.
  • Fig. 3 illustrates an example of the configuration of the sheet device 200.
  • Fig. 3 illustrates a portion of the entire sheet device 200.
  • the sheet device 200 has a configuration in which the skin-condition sensors 220 and light-emitting device units 500 are embedded in the sheet member 210.
  • Each skin-condition sensor 220 detects the condition of a portion of the skin adjacent to the skin-condition sensor.
  • each skin-condition sensor 220 is a blood flow sensor that measures the blood flow in the skin capillaries of the skin at the adjacent portion.
  • a blood-flow detection surface of each skin-condition sensor 220 is exposed from the surface of the sheet member 210 that comes into contact with the skin.
  • Each light-emitting device unit 500 includes multiple light-emitting devices that emit light having different wavelengths.
  • each light-emitting device unit 500 includes a light-emitting device 230 y , which is a yellow LED, a light-emitting device 230 r , which is a red LED, a light-emitting device 230 n , which is a near infrared LED, and a light-emitting device 230 b , which is a blue LED.
  • Light emission surfaces of the light-emitting devices 230 y , 230 r , 230 n , and 230 b are exposed from the surface of the sheet member 210 that comes into contact with the skin.
  • Each of the multiple skin-condition sensors may correspond to multiple light-emitting device units.
  • the light-emitting device 230 y which is a yellow LED, emits light of the yellow range in which the wavelength ranges from 570 nm to 590 nm.
  • the light-emitting device 230 y is configured and disposed so that, for example, the irradiance of approximately 0.1 mW/cm 2 is obtained at the surface of the sheet device 200 that closely adheres to the skin.
  • the light-emitting device 230 r which is a red LED, emits light of the red range in which the wavelength ranges from 620 nm to 750 nm.
  • the light-emitting device 230 r is configured and disposed so that, for example, the irradiance of approximately 1 mW/cm 2 is obtained at the surface of the sheet device 200 that closely adheres to the skin.
  • the light-emitting device 230 n which is a near infrared LED, emits light of the near infrared range in which the wavelength ranges from 800 nm to 1000 nm.
  • the light-emitting device 230 n is configured and disposed so that, for example, the irradiance of approximately 1 mW/cm 2 is obtained at the surface of the sheet device 200 that closely adheres to the skin.
  • the light-emitting device 230 b which is a blue LED, emits light of the blue range in which the wavelength ranges from 440 nm to 490 nm.
  • the light-emitting device 230 b is configured and disposed so that, for example, the irradiance of approximately 1 mW/cm 2 is obtained at the surface of the sheet device 200 that closely adheres to the skin.
  • light emission of the light-emitting device 230 y which is a yellow LED, has effects of reduction of discoloration and darkening and shrinkage of the pores.
  • Irradiation of the skin with light of the red range enhances the blood circulation, collagen formation, and activation of fibroblast.
  • light emission of the light-emitting device 230 r which is a red LED, has an effect of reduction of wrinkles or slackening.
  • Irradiation of the skin with light of the near infrared range has effects of expansion of capillaries, improvement of blood circulation, acceleration of metabolism, enhancement of tissue regeneration capability, muscle relaxation, and enhancement of collagen formation.
  • light emission of the light-emitting device 230 n which is a near infrared LED, has effects of lessening nasolabial folds, lifting up the skin, and reducing fine wrinkles.
  • Irradiation of the skin with light of the blue range has effects of suppression of occurrence of active oxygen and disinfection.
  • light emission of the light-emitting device 230 b which is a blue LED, has an effect of reduction of acne or eczema.
  • the skin-condition sensors and the light-emitting devices in the disclosure be sized as small as possible.
  • Examples usable as a small-sized skin-condition sensor include a blood flow sensor described in " Wearable Laser Blood Flowmeter” written by Takanori Kiyokura, Shinji Mino, and Junichi Shimada in NTT Technical Review Nov. 2005, issued by Nippon Telegram and Telephone Corporation (NTT Microsystem Integration Laboratories), pp. 25 to 27 . Between a laser diode and a phototransistor included in the blood flow sensor, an organic phototransistor formed by a polymer thin film transistor described in Japanese Unexamined Patent Application Publication No. 2007-300112 is usable as the phototransistor.
  • examples usable as a small-sized light-emitting device include an organic LED formed by printing using a polymer described in Japanese Unexamined Patent Application Publication No. 2009-48837 .
  • Fig. 4 schematically illustrates an example of the configuration of the skin-condition sensor 220 including an organic thin film transistor.
  • the skin-condition sensor 220 has a configuration in which a gate insulating layer 533 and an organic molecule layer 534 are stacked on a gate electrode layer 532 disposed on the surface of an elastic base member 531 and in which a source electrode 535 and a drain electrode 536 are disposed on the surface of the organic molecule layer 534 while being spaced apart from each other.
  • the sheet device 200 includes M skin-condition sensors 220 1 to 220 M .
  • Part of the sheet member 210 may form the elastic base member used for the skin-condition sensor.
  • each section of the sheet device 200 or each unit by which the sheet device 200 is controlled is called a "block".
  • Fig. 5 illustrates an example of an arrangement of blocks in the sheet device 200.
  • Fig. 5 corresponds to Fig. 2A .
  • the blocks include a block corresponding to a center portion of the forehead and a block corresponding to the right upper eyelid.
  • the sheet device 200 can individually control turning on/off of light or the intensity of light with which the center portion of the forehead and the right upper eyelid are irradiated.
  • the sheet device 200 may also include a block 540 i corresponding to a right eyelid and a block 540 j corresponding to a left eyelid.
  • the eyelids are irradiated with light because of the following reasons.
  • the eyelids are more likely to develop wrinkles due to a muscular decline because the skin of the eyelids is thin and blinking causes frequent muscular movement.
  • the eyelids are portions on which thick makeup is put and thus likely to be damaged by frictions at the time of cleansing.
  • the eyelids are more likely to become wrinkled, slackened, and dried. For these reasons, rejuvenation of the skin of the eyelids by irradiation with light is highly significant.
  • the skin-condition sensors and the light-emitting device units on the sheet device 200 may be arranged at a uniform density throughout the blocks, at different densities between different blocks, or at different densities within each block.
  • Each block may have at least one light-emitting device unit.
  • the type of light-emitting device unit and/or the number of light-emitting device units included in each block may be appropriately determined.
  • the type of light-emitting device unit and/or the number of light-emitting device units included in each block may be different or the same between different blocks.
  • Fig. 6 illustrates an example of the functional configuration of the phototherapeutic device 100.
  • the phototherapeutic device 100 includes a sheet device 200, which includes first to Mth skin-condition sensors 220 1 to 220 M and first to Nth light-emitting device units 230 1 to 230 N , and a control unit 300, which includes an information storage unit 310 and an operation determining unit 320.
  • control rule table a table that describes which skin-condition sensor and which light-emitting device unit belong to which block (see Fig. 5 ) and how each block is to be controlled.
  • Fig. 7 illustrates examples of the contents of the control rule table.
  • control rule table 550 describes skin-condition-sensor identification information 552 and light-emitting-device-unit identification information 553 for each block in correspondence with block identification information 551.
  • the control rule table 550 also describes a threshold parameter 554 in correspondence with the block identification information 551.
  • the threshold parameter 554 is a parameter used to determine whether or not light emission should be stopped and represents a value at which the skin is fully rejuvenated by light irradiation and before the light irradiation becomes excessive.
  • the threshold parameter 554 expresses an upper limit of an increase of the blood flow as a result of irradiation of light by a ratio of an increase to an initial blood flow.
  • the threshold parameter 554 may be the same throughout the first to Lth block 540 1 to 540 L or different between different blocks.
  • the operation determining unit 320 in Fig. 6 is connected to the first to Mth skin-condition sensors 220 1 to 220 M and the first to Nth light-emitting device units 230 1 to 230 N using the cable 400, which connects the control unit 300 and the sheet device 200, and a cable (not illustrated) embedded in the sheet device 200.
  • the operation determining unit 320 is capable of controlling the operation of the first to Mth skin-condition sensors 220 1 to 220 M by transmitting control signals to the first to Mth skin-condition sensors 220 1 to 220 M and capable of inputting detection values output from the first to Mth skin-condition sensors 220 1 to 220 M .
  • the operation determining unit 320 is also capable of controlling the operation of the first to Nth light-emitting device units 230 1 to 230 N by transmitting control signals to the first to Nth light-emitting device units 230 1 to 230 N .
  • the operation determining unit 320 determines the operation of the light-emitting device units disposed in each block of the sheet device 200 on the basis of detection values output from the corresponding skin-condition sensors disposed in the block.
  • the operation determining unit 320 firstly causes specific light-emitting device units to emit light and repeatedly obtains the mean value of detection results output from the corresponding multiple skin-condition sensors in each block (hereinafter the value is referred to as a "block detection value").
  • the block detection value the mean value of detection results output from the corresponding multiple skin-condition sensors in each block.
  • the operation determining unit 320 periodically determines whether or not the degree to which the block detection value has changed after the start of light emission arrives at a predetermined threshold. The reason why the mean value is used for determination is to obtain highly reliable data.
  • the operation determining unit 320 stops or reduces light emission of the light-emitting device units in the block.
  • the predetermined threshold is determined using the block detection value obtained before the start of light emission and the threshold parameter 554 described in the control rule table 550.
  • the predetermined threshold is effective in preventing the irradiation of light from excessively rejuvenating the skin.
  • the operation determining unit 320 controls the operation of each light-emitting device unit so that each block is irradiated with light having an appropriate intensity.
  • the predetermined threshold is described in detail below.
  • control unit 300 includes, for example, a central processing unit (CPU), a storage medium such as a read only memory (ROM) in which a control program is stored, and an operation memory such as a random access memory (RAM).
  • CPU central processing unit
  • ROM read only memory
  • RAM random access memory
  • control unit 300 includes a power source unit and an operation unit such as a key switch.
  • the power source unit supplies power to operate the CPU and the sheet device 200.
  • the operation unit receives various operations including an operation of starting light emission from a user.
  • the phototherapeutic device 100 having this configuration is capable of emitting light with an intensity appropriate for each portion of the skin.
  • Fig. 8 is a flowchart illustrating an example of the operation of the phototherapeutic device 100.
  • the phototherapeutic device 100 starts the following processing when a user instructs the start of the operation in the state where the sheet device 200 is attached to the user's face.
  • the phototherapeutic device 100 allows users to select the wavelength of light that is to be emitted, that is, the effect that the user wants from light irradiation.
  • the description here is given on the assumption that an operation is performed so that light ranging through the yellow range, the red range, the near infrared range, and the blue range is emitted, that is, all the light-emitting devices 230 y , 230 r , 230 n , and 230 b (see Fig. 3 ) of the light-emitting device units 500 are caused to emit light.
  • Step S1100 the first to Mth skin-condition sensors 220 1 to 220 M measure the blood flow before light irradiation and output the measured results to the operation determining unit 320.
  • the operation determining unit 320 calculates the block detection value of each block and records the calculated value (hereinafter referred to as an "initial block detection value").
  • the first to Nth light-emitting device units 230 1 to 230 N start light emission (light irradiation of the skin). Since the blood flow does not start changing immediately after the start of light emission, measurement the blood flow may be started immediately after the start of light emission.
  • the irradiance and the maximum irradiation time at the start of light emission may be the same or different between the different light-emitting device units.
  • the eyelids have a skin thinner than other portions of the face and eyeballs are located under the eyelids.
  • the irradiance of light of the near infrared range or the red range, which particularly has a high capability of penetrating the skin, with which the blocks corresponding to the eyelids are irradiated is reduced compared to that of light with which other blocks are irradiated (for example, 1/10 the irradiance).
  • the irradiance is controlled by controlling, for example, the electric current that the operation determining unit 320 supplies to each light-emitting device unit.
  • the maximum irradiation time for the blocks corresponding to the eyelids be reduced compared to that for other blocks or a predetermined threshold for the blocks corresponding to the eyelids be lowered compared to that for other blocks.
  • the skin is rejuvenated in accordance with the wavelength and the intensity (irradiance and irradiation time) of light. Changes of the skin conditions as a result of the rejuvenation appear as the changes of the blood flow.
  • Step S1200 the operation determining unit 320 selects one of blocks 540 that are being irradiated with light.
  • the operation determining unit 320 handles a process up to a transition of operations after Step S1800, which is described below, as one processing cycle.
  • Step S1300 all the skin-condition sensors in the selected block are caused to measure the blood flow again.
  • the operation determining unit 320 calculates the block detection value from the newly obtained measurement values. If the block includes only one skin detection sensor, calculation of the mean value is not required.
  • the operation determining unit 320 then calculates the difference between the initial block detection value and the newly calculated block detection value for the selected block (hereinafter the difference is referred to as a "detection difference").
  • Step S1400 the operation determining unit 320 obtains the threshold parameter 554 corresponding to the selected block from the control rule table 550 (see Fig. 7 ).
  • the operation determining unit 320 calculates the threshold of the detection difference on the basis of the initial block detection value and the threshold parameter 554 for the selected block.
  • the threshold parameter 554 is assumed to be a value "40%", expressing the percentage of an increase of the blood flow with respect to the initial blood flow.
  • the operation determining unit 320 calculates the threshold by multiplying the initial block detection value by "0.4", which is a value obtained by dividing the value of the threshold parameter 554 by 100.
  • the operation determining unit 320 determines whether or not the detection difference calculated in Step S1300 has exceeded the calculated threshold (predetermined threshold). In the case where the detection difference has not exceeded the predetermined threshold (NO in S1400), the processing of the operation determining unit 320 proceeds to Step S1600. In the case where the detection difference has exceeded the predetermined threshold (YES in S1400), the processing of the operation determining unit 320 proceeds to Step S1500.
  • the case where the detection difference has not arrived at the predetermined threshold is the state where the skin has not yet been fully rejuvenated by light irradiation.
  • the case where the detection difference has arrived at the predetermined threshold is the state where the skin has been fully rejuvenated by light irradiation and before the light irradiation becomes excessive.
  • Step S1500 the operation determining unit 320 stops or reduces light emission of the light-emitting device units in the selected block.
  • the operation determining unit 320 gradually reduces the intensity of light from the light-emitting device units. This is for the purpose of preventing the blood-flow balance between adjacent blocks from being lost as a result of a sudden increase of the intensity difference between a block for which light emission is stopped or reduced and adjacent blocks to which light has been continuously emitted.
  • the intensity of light is gradually reduced, for example, at such a pace as to be approximately halved per minute.
  • Step S1600 the operation determining unit 320 determines whether or not there is any block that is being irradiated with light and that has not been selected in this cycle. In the case where there is any block that is being irradiated with light and that has not been selected (YES in S1600), the processing of the operation determining unit 320 proceeds to Step S1700. In the case where there is no block that is being irradiated with light and that has not been selected (NO in S1600), the processing of the operation determining unit 320 proceeds to Step S1800.
  • Step S1700 the operation determining unit 320 selects one of the blocks 540 that is being irradiated with light and that have not been selected and returns to Step S1300.
  • Step S1800 the operation determining unit 320 determines whether or not there is any block that is being irradiated with light. When there is any block that is being irradiated with light, (YES in S1800), the processing of the operation determining unit 320 returns to Step S1200. When there is no block that is being irradiated with light, (NO in S1800), the processing of the operation determining unit 320 is finished.
  • the phototherapeutic device 100 is capable of periodically monitoring each block to see whether or not the skin has been fully rejuvenated by light irradiation and capable of stopping the light irradiation before the light irradiation becomes excessive.
  • the phototherapeutic device 100 is capable of emitting light having an appropriate intensity to each portion of the skin in accordance with the condition of the portion without users having to determine the intensity or irradiance of light that is to be applied to the portion.
  • the phototherapeutic device 100 according to the embodiment is capable of rejuvenating the skin of the entire face in balance while excessive light irradiation is prevented even when the skin conditions of the entire face is not uniform.
  • the phototherapeutic device 100 according to the embodiment is capable of effectively rejuvenating the skin.
  • the phototherapeutic device 100 emits not only light of a color effective for rejuvenation of the skin but also light of a blue range that has an effect of sterilizing acne bacteria.
  • the phototherapeutic device 100 is capable of further satisfying users, particularly the younger generation.
  • the phototherapeutic device 100 is also capable of emitting light without the user holding the device with his/her hands. Thus, the user can use the phototherapeutic device 100 while performing other operations.
  • the phototherapeutic device 100 is capable of saving power consumption to obtain the same irradiance since the distance from the light source to the skin is short, whereby the phototherapeutic device 100 can perform phototherapy in an environment-friendly manner.
  • the phototherapeutic device 100 also emits light of the red range.
  • the phototherapeutic device 100 is also effective in promoting the growth of, such as, eyebrows, eyelashes, hairline at the forehead, or beard.
  • the phototherapeutic device 100 can promote the growth of, for example, chest hair.
  • the operation determining unit 320 may determine the type (color) of light and the initial irradiance of light with which each block is irradiated in accordance with the skin conditions.
  • the phototherapeutic device 100 is configured so that the operation determining unit 320 is capable of individually controlling the operation of the light-emitting devices of different colors.
  • a table that describes the skin conditions and the operations that are to be performed by the different light-emitting devices in association with each other is stored in advance in the information storage unit 310.
  • the skin condition sensors are sensors that are capable of detecting whether or not the corresponding portions are in the skin condition described in the table.
  • the operation determining unit 320 determines the operation of the light-emitting devices with reference to the table.
  • the discoloration of the skin can be detected by comparing the colors of different portions of the skin. Particularly, when detection is performed with emission of blue light, the discoloration formed at a deep portion of the skin can be accurately detected. The discoloration can be reduced by being irradiated with light of the yellow range.
  • Each skin-condition sensor may include a tone sensor to detect the tone of the skin.
  • a tone sensor examples usable as a tone sensor include a device that measures the intensity of light having wavelengths corresponding to colors of RGB using a photosensor or a device that can capture three primary colors of RGB using an organic semiconductor device described in " Trend in Research on Organic Imaging Devices” written by Satoshi AIHARA and Misao KUBOTA, in NHK Science & Technology Research Laboratories R&D No. 132, issued by NHK Science & Technology Research Laboratories, in March 2012, pp. 4 to 11 .
  • the tone sensor described in " Trend in Research on Organic Imaging Devices " written by Satoshi AIHARA and Misao KUBOTA, in NHK Science & Technology Research Laboratories R&D No. 132, issued by NHK Science & Technology Research Laboratories, in March 2012, pp. 4 to 11 can be finely fabricated by printing.
  • the operation determining unit 320 compares the detected tones of different portions of the skin and determines, block by block, whether or not each block has discoloration and how much degree the discoloration is. The operation determining unit 320 then determines the intensity of light of the yellow range for each block in accordance with the determined results. Specifically, the operation determining unit 320 increases the irradiance of light with which a block having heavy discoloration is irradiated by, for example, raising the predetermined threshold for the block having heavy discoloration compared to the threshold for other blocks to increase the irradiation time for the block having heavy discoloration.
  • a table that describes, for example, the information indicating the skin conditions, the irradiance for each color range, the threshold corresponding to the upper limit of rejuvenation of the skin for each color range, and the maximum irradiation time for each color range in association with one another has to be stored in advance in the information storage unit 310.
  • each skin-condition sensor includes a tone sensor
  • the operation determining unit 320 may reduce or stop emission of light applied to each block when the degree of change of the skin color has arrived at a predetermined threshold. This is because the skin color represents the state of blood circulation (darkening) of the skin, that is, the degree of rejuvenation of the skin.
  • each skin-condition sensor includes a tone sensor
  • the tone sensor may detect the skin tone using light emitted from light sources other than the light-emitting device units. This is because the tone sensor is not used for image capturing and thus reflected light obtained when ambient light such as illumination from a dresser is incident on and reflected off the skin is bright enough for use in the spectroscopic analysis. In this case, the sheet member 210 needs to allow light to pass therethrough.
  • the tone sensor is disposed on the sheet device 200 in such a manner as not to come into contact with the skin so that the toner sensor can capture light reflected off the skin.
  • Fig. 9 illustrates an example of a cross section of the sheet device 200 including a tone sensor.
  • Fig. 9 illustrates a portion of the entire sheet device 200.
  • the light emission surface 231 of each light-emitting device 230 is positioned substantially flush with the surface 211 of the sheet member 210 that comes into close contact with the skin (the surface is hereinafter referred to as a "close contact surface”).
  • the light receiving surface 221 of the skin-condition sensor 220 (tone sensor) is set back inward from the close contact surface 211 of the sheet member 210.
  • the light receiving surface 221 of the skin-condition sensor 220 is spaced apart from the skin by approximately 100 micrometers while the close contact surface 211 of the sheet member 210 is in close contact with the skin.
  • the operation determining unit 320 has a function of calibrating outputs from the light-emitting devices of different colors. The calibration is performed by, for example, adjusting outputs from the light-emitting devices so that the detection values from the tone sensor obtained when white paper is applied to the close contact surface 211 of the sheet member 210 approximate a predetermined value.
  • the phototherapeutic device 100 may include a temperature sensor as a skin-condition sensor and stop light emission in accordance with the change of the detected skin temperature.
  • a temperature sensor as a skin-condition sensor and stop light emission in accordance with the change of the detected skin temperature.
  • an example usable as a standard for determining a stop of light emission is an increase in temperature by one degree. It is desirable that the determination with respect to the temperature be made on the basis of the absolute values whereas the determination with respect to the blood flow be made on the basis of the relative values.
  • An example usable as a temperature sensor is a temperature sensor in which an organic molecule layer of an organic thin film transistor is formed of a phthalocyanine nano-size structure (see, for example, International Publication No. 2013/151128 ).
  • the phototherapeutic device 100 may alternatively control light emission on the basis of both the change of blood flow and the change of the temperature. In this case, it is desirable that the phototherapeutic device 100 stop emission of light applied to eyelid portions when the degree of change of the temperature at the eyelid portions exceeds a predetermined threshold regardless of the degree of the change of blood flow to prevent the high temperature from imposing a load on the skin at the eyelid portions.
  • the phototherapeutic device can have a high temperature due to a breakdown, whereby stopping light emission in response to such a temperature change also enhances the product safety.
  • At least one of the functions of the control unit 300 according to the second embodiment may be implemented by other devices having different functions, such as mobile phones.
  • At least one of the functions of the control unit 300 may be implemented by a network server. Specifically, at least one of the functions of the phototherapeutic device may be implemented by cloud computing. In this case, the operation determining unit needs to include at least a communication unit, transmit data of the skin conditions to the server, and obtain timing of stopping light emission.
  • a sheet that covers portions of the body other than the face is usable in the phototherapeutic device 100.
  • the use of the phototherapeutic device 100 can effectively reduce macular discoloration on the back due to a sunburn or other causes.
  • the phototherapeutic device 100 may have operation determining units 320 corresponding to different blocks, each of the operation determining units 320 performing operations for the corresponding block.
  • the phototherapeutic device of this disclosure includes a sheet member that is attachable to a skin; a skin-condition sensor that is disposed in the sheet member and that detects information related to a condition of the skin; and a light-emitting device unit that is disposed in the sheet member, the light-emitting device unit operating on the basis of the information detected by the skin-condition sensor, wherein the light-emitting device unit includes a plurality of light-emitting devices that emit light having different wavelengths.
  • the light-emitting device unit may reduce or stop light emission when the degree to which the information detected by the skin-condition sensor changes arrives at a predetermined threshold after a start of the light emission.
  • a plurality of skin-condition sensors may be disposed at different positions of the sheet member, each of the skin-condition sensors may detect information related to a condition of a portion of the skin, a plurality of light-emitting device units may be disposed at different positions of the sheet member, each of the light-emitting device units may be disposed at a position corresponding to at least one of the skin-condition sensors, each of the light-emitting device units may operate on the basis of the information detected by the at least one corresponding skin-condition sensor.
  • the sheet member may be attached to a predetermined portion of a face
  • the light-emitting device unit may irradiate the skin with predetermined light that facilitates rejuvenation of the skin
  • the skin-condition sensor may detect at least one of a blood flow and a temperature of the skin as the information related to the condition
  • the predetermined threshold may be determined for each of the light-emitting devices by using, as a reference, the condition of the skin before the information detected by the skin-condition sensor changes.
  • the sheet member may include a first region corresponding to one eyelid portion of the face and a second region different from the first region
  • the plurality of light-emitting device units may include a second light-emitting device unit disposed in the first region and a third light-emitting device unit disposed in the second region
  • the second light-emitting device unit emits light having an intensity lower than an intensity of light emitted by the third light-emitting device unit
  • a predetermined threshold for the second light-emitting device unit may be lower than a predetermined threshold for the third light-emitting device unit.
  • each of the light-emitting device units may gradually reduce the intensity of light when stopping the light emission.
  • the sheet member may include a plurality of sections, at least one of the skin-condition sensors may be disposed in each of the sections, at least one of the light-emitting device units may be disposed in each of the sections, and the phototherapeutic device may include an operation determining unit that determines an operation of the at least one light-emitting device unit disposed in one section on the basis of information detected by the at least one skin-condition sensor disposed in said one section.
  • the light-emitting device unit may include a blue light emitting device
  • the skin-condition sensor may detect a tone of the skin as the information related to the condition of the skin in a state where the blue light emitting device is emitting light
  • the operation determining unit may determine an intensity of light that is to be emitted by the light-emitting device unit on the basis of the tone.
  • the sheet member may be detachably connected to the operation determining unit using a connector and a cable.
  • a phototherapeutic method include detecting information related to a condition of a skin using a skin-condition sensor disposed on a sheet member attachable to the skin; and operating a light-emitting device unit disposed in the sheet member on the basis of the information detected by the skin-condition sensor.
  • the disclosure is usable as a device such as a phototherapeutic device that can more effectively rejuvenate the skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiation-Therapy Devices (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Description

    BACKGROUND 1. Technical Field:
  • The present disclosure relates to a phototherapeutic device and a phototherapeutic method.
  • 2. Description of the Related Art:
  • To date, a cosmetic device (see Japanese Unexamined Patent Application Publication No. 2013-154229 ) that irradiates the skin with light guided from a lens or an optical facial beautifying mask (see Japanese Unexamined Patent Application Publication No. 2005-27702 ) including a light source unit that irradiates the face with light having different hues through a mask have been disclosed.
  • WO 2012/011042 A2 relates to an apparatus for bio-stimulating phototherapy. US 2013/066404 A1 relates to a light therapy platform system. US 2005/0177093 A1 relates to a tissue inflammation therapy and monitoring device. KR 10-0963687 B1 relates to a massage machine. US 2007/129776 A1 relates to an external wearable light therapy treatment system.
  • SUMMARY
  • However, the above-described configurations have difficulty in effectively rejuvenating the skin.
  • One non-limiting and exemplary embodiment provides a phototherapeutic device according to claim 1 that can more effectively rejuvenate the skin. A phototherapeutic cosmetic method is defined in claim 6.
  • Additional benefits and advantages of the disclosed embodiments will be apparent from the dependent claims, specification and figures. The benefits and/or advantages may be individually provided by the various embodiments and features of the specification and drawings disclosure, and need not all be provided in order to obtain one or more of the same.
  • In one general aspect, the techniques disclosed here feature a phototherapeutic device as defined in claim 1.
  • Note that general and specific aspects of the present disclosure may be implemented in a form of a method as defined in claim 6.
  • A phototherapeutic device disclosed herein can more effectively rejuvenate the skin.
  • BRIEF DESCRIPTION OF THE DRAWINGS
    • Fig. 1 illustrates an example of the configuration of a phototherapeutic device according to a first embodiment of the disclosure.
    • Figs. 2A and 2B illustrate an example of an appearance of a phototherapeutic device according to a second embodiment of the disclosure.
    • Fig. 3 illustrates an example of the configuration of a sheet device according to the second embodiment.
    • Fig. 4 schematically illustrates an example of the configuration of a skin-condition sensor according to the second embodiment.
    • Fig. 5 illustrates an example of an arrangement of blocks according to the second embodiment.
    • Fig. 6 illustrates an example of the functional configuration of the phototherapeutic device according to the second embodiment.
    • Fig. 7 illustrates an example of contents in a control rule table according to the second embodiment.
    • Fig. 8 is a flowchart illustrating an example of the operation of the phototherapeutic device according to the second embodiment.
    • Fig. 9 illustrates an example of a cross section of the sheet device according to the second embodiment.
    DETAILED DESCRIPTION Underlying Knowledge
  • Cosmetic devices used to rejuvenate the skin by irradiating the skin with light (hereinafter referred to as "phototherapeutic devices") have been developed (see, for example, Japanese Unexamined Patent Application Publication Nos. 2013-154229 and 2005-27702 ). Here, rejuvenation of the skin is a concept including, for example, improvement of blood circulation, activation of fibroblast, improvement of lymphatic circulation, whitening, suppression of occurrence of active oxygen, expansion of capillaries, acceleration of metabolism, enhancement of tissue regeneration capability, and muscle relaxant.
  • A phototherapeutic device described in Japanese Unexamined Patent Application Publication No. 2013-154229 has a light emission port, through which light is emitted, at an end of a hand-held cylindrical body. A phototherapeutic device described in Japanese Unexamined Patent Application Publication No. 2005-27702 includes a large number of light emitting diodes (LEDs) disposed on a face sheet that covers the entire face.
  • The user applies the light emission port of the phototherapeutic device according to Japanese Unexamined Patent Application Publication No. 2013-154229 to a portion of the skin that the user desires to rejuvenate. Instead, the user covers the entirety of his/her face with the face sheet described in Japanese Unexamined Patent Application Publication No. 2005-27702 . Thus, the technologies of Japanese Unexamined Patent Application Publication Nos. 2013-154229 and 2005-27702 (hereinafter referred to as "existing technologies") can rejuvenate the skin and improve the skin conditions.
  • The intensity of light (irradiance and irradiation time) with which the phototherapeutic device irradiates the skin differs depending on the conditions of the skin including the thickness of discoloration, the degree of darkening, or the degree of activation of fibroblast. For example, a portion having thicker discoloration requires an irradiation with intenser light. On the other hand, an excessive irradiation of a portion of the skin that has fully been rejuvenated with light is not desirable. Thus, desirably, each portion of the skin is irradiated with light having an appropriate intensity that is neither too low nor too high.
  • The skin conditions, however, are usually uneven and thus appropriately irradiating the entirety of the skin with light is difficult. Moreover, even in the case where each portion is individually irradiated with light, appropriately determining which portion of the skin is to be irradiated with light of how much intensity or for how long is difficult. In other words, existing technologies have difficulty in effectively rejuvenating the skin.
  • To address this situation, a phototherapeutic device of the disclosure is defined in claim 1.
  • Thus, the phototherapeutic device of the disclosure can more effectively rejuvenate the skin.
  • Referring now to the drawings, embodiments of the disclosure are described in detail below.
  • First Embodiment
  • A first embodiment of the disclosure is an example of a basic form of the disclosure.
  • Fig. 1 illustrates an example of the configuration of a phototherapeutic device 100 according to this embodiment.
  • In Fig. 1, the phototherapeutic device 100 includes a sheet member 210, first to Mth skin-condition sensors 2201 to 220M, and first to Nth light-emitting device units 2301 to 230N.
  • The sheet member 210 is a member that can be attached to the skin.
  • The first to Mth skin-condition sensors 2201 to 220M are disposed in the sheet member 210 at different positions of the sheet member 210. Each of the first to Mth skin-condition sensors 2201 to 220M detects the conditions of a portion of the skin adjacent to the skin-condition sensor.
  • The first to Nth light-emitting device units 2301 to 230N are disposed at positions on the sheet member 210 corresponding to the positions of the respective first to Mth skin-condition sensors 2201 to 220M. The first to Nth light-emitting device units 2301 to 230N operate in accordance with information related to the condition detected by the corresponding skin-condition sensors.
  • Each of the light-emitting device units 2301 to 230N includes multiple light-emitting devices that emit light having different wavelengths.
  • Each of the light-emitting device units 2301 to 230N may reduce or stop light emission when the degree to which the information detected by the corresponding skin-condition sensor has changed after the start of light emission has arrived at a predetermined threshold.
  • Since the phototherapeutic device 100 can irradiate each portion of the skin with light appropriate for the conditions of the portion, the skin can be effectively rejuvenated.
  • The phototherapeutic device 100 may have only one skin-condition sensor on the sheet member 210 instead of multiple skin-condition sensors. The phototherapeutic device 100 may have only one light-emitting device unit on the sheet member 210 instead of multiple light-emitting device units.
  • Second Embodiment
  • A second embodiment of the disclosure is an example of a specific form when the disclosure is applied to a face sheet that covers the entire face.
  • Appearance and Configuration of Phototherapeutic Device
  • Firstly, the appearance and the configuration of a phototherapeutic device 100 according to the embodiment will be described.
  • Appearance of Phototherapeutic Device
  • Figs. 2A and 2B illustrate an example of the appearance of the phototherapeutic device 100 according to the embodiment. Fig. 2A illustrates the appearance of the phototherapeutic device 100 when viewed from the side. Fig. 2B illustrates the appearance of the phototherapeutic device 100 when viewed from the front.
  • As illustrated in Figs. 2A and 2B, the phototherapeutic device 100 includes a sheet device 200 and a control unit 300.
  • The sheet device 200 is a device having a three-dimensional shape that covers the face, both ears, the submandibular portion (these portions are collectively called the "face", as appropriate below) and the surface of the neck. The base material of the sheet device 200 is a sheet member having elasticity and flexibility. Examples usable as the base material include a sheet member formed of a cured product of an energy-ray curable composition containing an acryloyl group-terminated urethane polymer and an acrylic monomer (see Japanese Unexamined Patent Application Publication No. 2013-168575 ).
  • The sheet device 200 has slits shaped so as to correspond to the shape of the closed eyes and openings shaped so as to correspond to the nostrils. Specifically, compared to typical face sheets, the sheet device 200 has a characteristic shape that covers the neck portion in addition to the upper eyelid, the lower eyelid, the lips, the ears, and the submandibular portion.
  • When placed at a predetermined portion of the face, the sheet device 200 can keep closely adhering to the skin surface of the entire face with the effect of the surface tension. For securing sufficient adherence, a biocompatible adhesive such as spirit gum, a silicone adhesive, or a latex adhesive may additionally be used. It is desirable that the sheet device 200 can be selected from among multiple sizes in accordance with various sizes of the face.
  • On the surface of the sheet member serving as the sheet device 200 on the side on which the sheet member closely adheres to the face, multiple skin-condition sensors and multiple light-emitting device units (see Fig. 3) are disposed. The configuration of the sheet device 200 on which the multiple skin-condition sensors and the multiple light-emitting device units are arranged will be described in detail below.
  • The control unit 300 is a unit protected by a housing made of a material such as plastics. The control unit 300 is connected to the sheet device 200 using a cable 400. Specifically, the control unit 300 is connected to each of the first to Mth skin-condition sensors 2201 to 220M of the sheet device 200. The control unit 300 is connected to each of the first to Nth light-emitting device units 2301 to 230N of the sheet device 200. It is desirable that the cable 400 have such a length that the control unit 300 can be held in a pocket of the user's cloth.
  • It is desirable that the sheet device 200 and the control unit 300 be attachable to and detachable from each other using a connector 401 and the cable 400. This configuration enables replacement of the sheet device 200 with a new sheet device every time the user uses it.
  • Configuration of Sheet Device
  • Fig. 3 illustrates an example of the configuration of the sheet device 200. Fig. 3 illustrates a portion of the entire sheet device 200.
  • In Fig. 3, the sheet device 200 has a configuration in which the skin-condition sensors 220 and light-emitting device units 500 are embedded in the sheet member 210.
  • Each skin-condition sensor 220 detects the condition of a portion of the skin adjacent to the skin-condition sensor. In this embodiment, each skin-condition sensor 220 is a blood flow sensor that measures the blood flow in the skin capillaries of the skin at the adjacent portion. A blood-flow detection surface of each skin-condition sensor 220 is exposed from the surface of the sheet member 210 that comes into contact with the skin.
  • Each light-emitting device unit 500 includes multiple light-emitting devices that emit light having different wavelengths. In this embodiment, each light-emitting device unit 500 includes a light-emitting device 230y, which is a yellow LED, a light-emitting device 230r, which is a red LED, a light-emitting device 230n, which is a near infrared LED, and a light-emitting device 230b, which is a blue LED. Light emission surfaces of the light-emitting devices 230y, 230r, 230n, and 230b are exposed from the surface of the sheet member 210 that comes into contact with the skin.
  • Each of the multiple skin-condition sensors may correspond to multiple light-emitting device units.
  • The light-emitting device 230y, which is a yellow LED, emits light of the yellow range in which the wavelength ranges from 570 nm to 590 nm. The light-emitting device 230y is configured and disposed so that, for example, the irradiance of approximately 0.1 mW/cm2 is obtained at the surface of the sheet device 200 that closely adheres to the skin.
  • The light-emitting device 230r, which is a red LED, emits light of the red range in which the wavelength ranges from 620 nm to 750 nm. The light-emitting device 230r is configured and disposed so that, for example, the irradiance of approximately 1 mW/cm2 is obtained at the surface of the sheet device 200 that closely adheres to the skin.
  • The light-emitting device 230n, which is a near infrared LED, emits light of the near infrared range in which the wavelength ranges from 800 nm to 1000 nm. The light-emitting device 230n is configured and disposed so that, for example, the irradiance of approximately 1 mW/cm2 is obtained at the surface of the sheet device 200 that closely adheres to the skin.
  • The light-emitting device 230b, which is a blue LED, emits light of the blue range in which the wavelength ranges from 440 nm to 490 nm. The light-emitting device 230b is configured and disposed so that, for example, the irradiance of approximately 1 mW/cm2 is obtained at the surface of the sheet device 200 that closely adheres to the skin.
  • Various researches have reported the relationship between the color (wavelength range) and the irradiance of light emitted by a light-emitting device and the effect on the skin (for example, see Japanese Unexamined Patent Application Publication No. 2011-41706 ).
  • Irradiation of the skin with light of the yellow range enhances the lymphatic circulation and whitening. Thus, light emission of the light-emitting device 230y, which is a yellow LED, has effects of reduction of discoloration and darkening and shrinkage of the pores.
  • Irradiation of the skin with light of the red range enhances the blood circulation, collagen formation, and activation of fibroblast. Thus, light emission of the light-emitting device 230r, which is a red LED, has an effect of reduction of wrinkles or slackening.
  • Irradiation of the skin with light of the near infrared range has effects of expansion of capillaries, improvement of blood circulation, acceleration of metabolism, enhancement of tissue regeneration capability, muscle relaxation, and enhancement of collagen formation. Thus, light emission of the light-emitting device 230n, which is a near infrared LED, has effects of lessening nasolabial folds, lifting up the skin, and reducing fine wrinkles.
  • Irradiation of the skin with light of the blue range has effects of suppression of occurrence of active oxygen and disinfection. Thus, light emission of the light-emitting device 230b, which is a blue LED, has an effect of reduction of acne or eczema.
  • It is desirable that the skin-condition sensors and the light-emitting devices in the disclosure be sized as small as possible.
  • Examples usable as a small-sized skin-condition sensor include a blood flow sensor described in "Wearable Laser Blood Flowmeter" written by Takanori Kiyokura, Shinji Mino, and Junichi Shimada in NTT Technical Review Nov. 2005, issued by Nippon Telegram and Telephone Corporation (NTT Microsystem Integration Laboratories), pp. 25 to 27. Between a laser diode and a phototransistor included in the blood flow sensor, an organic phototransistor formed by a polymer thin film transistor described in Japanese Unexamined Patent Application Publication No. 2007-300112 is usable as the phototransistor.
  • In addition, examples usable as a small-sized light-emitting device include an organic LED formed by printing using a polymer described in Japanese Unexamined Patent Application Publication No. 2009-48837 .
  • Configuration of Skin-Condition Sensor
  • Fig. 4 schematically illustrates an example of the configuration of the skin-condition sensor 220 including an organic thin film transistor.
  • As illustrated in Fig. 4, the skin-condition sensor 220 has a configuration in which a gate insulating layer 533 and an organic molecule layer 534 are stacked on a gate electrode layer 532 disposed on the surface of an elastic base member 531 and in which a source electrode 535 and a drain electrode 536 are disposed on the surface of the organic molecule layer 534 while being spaced apart from each other.
  • In this embodiment, the sheet device 200 includes M skin-condition sensors 2201 to 220M. Part of the sheet member 210 may form the elastic base member used for the skin-condition sensor.
  • Unit by Which Sheet Device Is Controlled
  • In this embodiment, the operation of the sheet device 200 is controlled per each section obtained by dividing the sheet device 200 into multiple sections. Hereinbelow, each section of the sheet device 200 or each unit by which the sheet device 200 is controlled is called a "block".
  • Fig. 5 illustrates an example of an arrangement of blocks in the sheet device 200. Fig. 5 corresponds to Fig. 2A.
  • As illustrated in Fig. 5, multiple blocks corresponding to small sections of the entire face, for example, L blocks 540l to 540L are defined in the sheet device 200. For example, the blocks include a block corresponding to a center portion of the forehead and a block corresponding to the right upper eyelid. Thus, the sheet device 200 can individually control turning on/off of light or the intensity of light with which the center portion of the forehead and the right upper eyelid are irradiated. The sheet device 200 may also include a block 540i corresponding to a right eyelid and a block 540j corresponding to a left eyelid.
  • The eyelids are irradiated with light because of the following reasons. The eyelids are more likely to develop wrinkles due to a muscular decline because the skin of the eyelids is thin and blinking causes frequent muscular movement. Moreover, particularly in the case of women, the eyelids are portions on which thick makeup is put and thus likely to be damaged by frictions at the time of cleansing. Thus, the eyelids are more likely to become wrinkled, slackened, and dried. For these reasons, rejuvenation of the skin of the eyelids by irradiation with light is highly significant.
  • The skin-condition sensors and the light-emitting device units on the sheet device 200 may be arranged at a uniform density throughout the blocks, at different densities between different blocks, or at different densities within each block.
  • Multiple skin-condition sensors are disposed in each of L blocks. The number of blocks and the arrangement of the blocks are not limited to those in the case illustrated in Fig. 5. Each block may have at least one light-emitting device unit. The type of light-emitting device unit and/or the number of light-emitting device units included in each block may be appropriately determined. The type of light-emitting device unit and/or the number of light-emitting device units included in each block may be different or the same between different blocks.
  • Functional Configuration of Phototherapeutic Device
  • Fig. 6 illustrates an example of the functional configuration of the phototherapeutic device 100.
  • In Fig. 6, the phototherapeutic device 100 includes a sheet device 200, which includes first to Mth skin-condition sensors 2201 to 220M and first to Nth light-emitting device units 2301 to 230N, and a control unit 300, which includes an information storage unit 310 and an operation determining unit 320.
  • In the information storage unit 310, a table that describes which skin-condition sensor and which light-emitting device unit belong to which block (see Fig. 5) and how each block is to be controlled (hereinbelow, the table is called a "control rule table") is stored in advance.
  • Fig. 7 illustrates examples of the contents of the control rule table.
  • As illustrated in Fig. 7, the control rule table 550 describes skin-condition-sensor identification information 552 and light-emitting-device-unit identification information 553 for each block in correspondence with block identification information 551. The control rule table 550 also describes a threshold parameter 554 in correspondence with the block identification information 551.
  • The threshold parameter 554 is a parameter used to determine whether or not light emission should be stopped and represents a value at which the skin is fully rejuvenated by light irradiation and before the light irradiation becomes excessive. For example, the threshold parameter 554 expresses an upper limit of an increase of the blood flow as a result of irradiation of light by a ratio of an increase to an initial blood flow. The threshold parameter 554 may be the same throughout the first to Lth block 5401 to 540L or different between different blocks.
  • The operation determining unit 320 in Fig. 6 is connected to the first to Mth skin-condition sensors 2201 to 220M and the first to Nth light-emitting device units 2301 to 230N using the cable 400, which connects the control unit 300 and the sheet device 200, and a cable (not illustrated) embedded in the sheet device 200. In other words, the operation determining unit 320 is capable of controlling the operation of the first to Mth skin-condition sensors 2201 to 220M by transmitting control signals to the first to Mth skin-condition sensors 2201 to 220M and capable of inputting detection values output from the first to Mth skin-condition sensors 2201 to 220M. The operation determining unit 320 is also capable of controlling the operation of the first to Nth light-emitting device units 2301 to 230N by transmitting control signals to the first to Nth light-emitting device units 2301 to 230N.
  • The operation determining unit 320 determines the operation of the light-emitting device units disposed in each block of the sheet device 200 on the basis of detection values output from the corresponding skin-condition sensors disposed in the block.
  • More specifically, the operation determining unit 320 firstly causes specific light-emitting device units to emit light and repeatedly obtains the mean value of detection results output from the corresponding multiple skin-condition sensors in each block (hereinafter the value is referred to as a "block detection value"). Here, if the block includes only one skin detection sensor, calculation of the mean value is not required. Then, the operation determining unit 320 periodically determines whether or not the degree to which the block detection value has changed after the start of light emission arrives at a predetermined threshold. The reason why the mean value is used for determination is to obtain highly reliable data. When the degree to which the block detection value has changed exceeds the predetermined threshold in any of the blocks, the operation determining unit 320 stops or reduces light emission of the light-emitting device units in the block.
  • The predetermined threshold is determined using the block detection value obtained before the start of light emission and the threshold parameter 554 described in the control rule table 550. The predetermined threshold is effective in preventing the irradiation of light from excessively rejuvenating the skin. Specifically, the operation determining unit 320 controls the operation of each light-emitting device unit so that each block is irradiated with light having an appropriate intensity. The predetermined threshold is described in detail below.
  • Although not illustrated, the control unit 300 includes, for example, a central processing unit (CPU), a storage medium such as a read only memory (ROM) in which a control program is stored, and an operation memory such as a random access memory (RAM). In this case, the function of each portion of the control unit 300 is implemented by the CPU executing the control program.
  • Although not illustrated, the control unit 300 includes a power source unit and an operation unit such as a key switch. The power source unit supplies power to operate the CPU and the sheet device 200. The operation unit receives various operations including an operation of starting light emission from a user.
  • The phototherapeutic device 100 having this configuration is capable of emitting light with an intensity appropriate for each portion of the skin.
  • Operation of Phototherapeutic Device
  • Now, the operation of the phototherapeutic device 100 is described.
  • Fig. 8 is a flowchart illustrating an example of the operation of the phototherapeutic device 100.
  • The phototherapeutic device 100 starts the following processing when a user instructs the start of the operation in the state where the sheet device 200 is attached to the user's face.
  • Desirably, the phototherapeutic device 100 allows users to select the wavelength of light that is to be emitted, that is, the effect that the user wants from light irradiation. The description here is given on the assumption that an operation is performed so that light ranging through the yellow range, the red range, the near infrared range, and the blue range is emitted, that is, all the light-emitting devices 230y, 230r, 230n, and 230b (see Fig. 3) of the light-emitting device units 500 are caused to emit light.
  • In Step S1100, the first to Mth skin-condition sensors 2201 to 220M measure the blood flow before light irradiation and output the measured results to the operation determining unit 320. The operation determining unit 320 calculates the block detection value of each block and records the calculated value (hereinafter referred to as an "initial block detection value"). The first to Nth light-emitting device units 2301 to 230N start light emission (light irradiation of the skin). Since the blood flow does not start changing immediately after the start of light emission, measurement the blood flow may be started immediately after the start of light emission.
  • The irradiance and the maximum irradiation time at the start of light emission may be the same or different between the different light-emitting device units. For example, the eyelids have a skin thinner than other portions of the face and eyeballs are located under the eyelids. Thus, desirably, the irradiance of light of the near infrared range or the red range, which particularly has a high capability of penetrating the skin, with which the blocks corresponding to the eyelids are irradiated is reduced compared to that of light with which other blocks are irradiated (for example, 1/10 the irradiance). The irradiance is controlled by controlling, for example, the electric current that the operation determining unit 320 supplies to each light-emitting device unit.
  • In addition, it is desirable that the maximum irradiation time for the blocks corresponding to the eyelids be reduced compared to that for other blocks or a predetermined threshold for the blocks corresponding to the eyelids be lowered compared to that for other blocks.
  • After light emission is started under such conditions, the skin is rejuvenated in accordance with the wavelength and the intensity (irradiance and irradiation time) of light. Changes of the skin conditions as a result of the rejuvenation appear as the changes of the blood flow.
  • In Step S1200, the operation determining unit 320 selects one of blocks 540 that are being irradiated with light. The operation determining unit 320 handles a process up to a transition of operations after Step S1800, which is described below, as one processing cycle.
  • In Step S1300, all the skin-condition sensors in the selected block are caused to measure the blood flow again. The operation determining unit 320 calculates the block detection value from the newly obtained measurement values. If the block includes only one skin detection sensor, calculation of the mean value is not required. The operation determining unit 320 then calculates the difference between the initial block detection value and the newly calculated block detection value for the selected block (hereinafter the difference is referred to as a "detection difference").
  • In Step S1400, the operation determining unit 320 obtains the threshold parameter 554 corresponding to the selected block from the control rule table 550 (see Fig. 7). The operation determining unit 320 calculates the threshold of the detection difference on the basis of the initial block detection value and the threshold parameter 554 for the selected block.
  • For example, the threshold parameter 554 is assumed to be a value "40%", expressing the percentage of an increase of the blood flow with respect to the initial blood flow. In this case, the operation determining unit 320 calculates the threshold by multiplying the initial block detection value by "0.4", which is a value obtained by dividing the value of the threshold parameter 554 by 100.
  • The operation determining unit 320 then determines whether or not the detection difference calculated in Step S1300 has exceeded the calculated threshold (predetermined threshold). In the case where the detection difference has not exceeded the predetermined threshold (NO in S1400), the processing of the operation determining unit 320 proceeds to Step S1600. In the case where the detection difference has exceeded the predetermined threshold (YES in S1400), the processing of the operation determining unit 320 proceeds to Step S1500.
  • Here, the case where the detection difference has not arrived at the predetermined threshold is the state where the skin has not yet been fully rejuvenated by light irradiation. The case where the detection difference has arrived at the predetermined threshold is the state where the skin has been fully rejuvenated by light irradiation and before the light irradiation becomes excessive.
  • In Step S1500, the operation determining unit 320 stops or reduces light emission of the light-emitting device units in the selected block. At this time, desirably, the operation determining unit 320 gradually reduces the intensity of light from the light-emitting device units. This is for the purpose of preventing the blood-flow balance between adjacent blocks from being lost as a result of a sudden increase of the intensity difference between a block for which light emission is stopped or reduced and adjacent blocks to which light has been continuously emitted. The intensity of light is gradually reduced, for example, at such a pace as to be approximately halved per minute.
  • In Step S1600, the operation determining unit 320 determines whether or not there is any block that is being irradiated with light and that has not been selected in this cycle. In the case where there is any block that is being irradiated with light and that has not been selected (YES in S1600), the processing of the operation determining unit 320 proceeds to Step S1700. In the case where there is no block that is being irradiated with light and that has not been selected (NO in S1600), the processing of the operation determining unit 320 proceeds to Step S1800.
  • In Step S1700, the operation determining unit 320 selects one of the blocks 540 that is being irradiated with light and that have not been selected and returns to Step S1300.
  • In Step S1800, the operation determining unit 320 determines whether or not there is any block that is being irradiated with light. When there is any block that is being irradiated with light, (YES in S1800), the processing of the operation determining unit 320 returns to Step S1200. When there is no block that is being irradiated with light, (NO in S1800), the processing of the operation determining unit 320 is finished.
  • By performing these operations, the phototherapeutic device 100 is capable of periodically monitoring each block to see whether or not the skin has been fully rejuvenated by light irradiation and capable of stopping the light irradiation before the light irradiation becomes excessive.
  • Effects of Phototherapeutic Device
  • As described above, the phototherapeutic device 100 according to the embodiment is capable of emitting light having an appropriate intensity to each portion of the skin in accordance with the condition of the portion without users having to determine the intensity or irradiance of light that is to be applied to the portion.
  • Thus, the phototherapeutic device 100 according to the embodiment is capable of rejuvenating the skin of the entire face in balance while excessive light irradiation is prevented even when the skin conditions of the entire face is not uniform. In short, the phototherapeutic device 100 according to the embodiment is capable of effectively rejuvenating the skin.
  • The phototherapeutic device 100 according to the embodiment emits not only light of a color effective for rejuvenation of the skin but also light of a blue range that has an effect of sterilizing acne bacteria. Thus, the phototherapeutic device 100 is capable of further satisfying users, particularly the younger generation.
  • The phototherapeutic device 100 according to the embodiment is also capable of emitting light without the user holding the device with his/her hands. Thus, the user can use the phototherapeutic device 100 while performing other operations.
  • The phototherapeutic device 100 according to the embodiment is capable of saving power consumption to obtain the same irradiance since the distance from the light source to the skin is short, whereby the phototherapeutic device 100 can perform phototherapy in an environment-friendly manner.
  • The phototherapeutic device 100 according to the embodiment also emits light of the red range. Thus, the phototherapeutic device 100 is also effective in promoting the growth of, such as, eyebrows, eyelashes, hairline at the forehead, or beard. In the case where a sheet that covers other portions of the body besides the face, which will be described below, is used in the phototherapeutic device 100, the phototherapeutic device 100 can promote the growth of, for example, chest hair.
  • Modified Example of Phototherapeutic Device
  • The operation determining unit 320 may determine the type (color) of light and the initial irradiance of light with which each block is irradiated in accordance with the skin conditions.
  • In this case, the phototherapeutic device 100 is configured so that the operation determining unit 320 is capable of individually controlling the operation of the light-emitting devices of different colors. A table that describes the skin conditions and the operations that are to be performed by the different light-emitting devices in association with each other is stored in advance in the information storage unit 310. The skin condition sensors are sensors that are capable of detecting whether or not the corresponding portions are in the skin condition described in the table. On the basis of the detection results of each skin-condition sensor, the operation determining unit 320 determines the operation of the light-emitting devices with reference to the table.
  • For example, the discoloration of the skin can be detected by comparing the colors of different portions of the skin. Particularly, when detection is performed with emission of blue light, the discoloration formed at a deep portion of the skin can be accurately detected. The discoloration can be reduced by being irradiated with light of the yellow range.
  • Each skin-condition sensor may include a tone sensor to detect the tone of the skin. Examples usable as a tone sensor include a device that measures the intensity of light having wavelengths corresponding to colors of RGB using a photosensor or a device that can capture three primary colors of RGB using an organic semiconductor device described in "Trend in Research on Organic Imaging Devices" written by Satoshi AIHARA and Misao KUBOTA, in NHK Science & Technology Research Laboratories R&D No. 132, issued by NHK Science & Technology Research Laboratories, in March 2012, pp. 4 to 11. The tone sensor described in " Trend in Research on Organic Imaging Devices " written by Satoshi AIHARA and Misao KUBOTA, in NHK Science & Technology Research Laboratories R&D No. 132, issued by NHK Science & Technology Research Laboratories, in March 2012, pp. 4 to 11 can be finely fabricated by printing.
  • In this case, the operation determining unit 320 compares the detected tones of different portions of the skin and determines, block by block, whether or not each block has discoloration and how much degree the discoloration is. The operation determining unit 320 then determines the intensity of light of the yellow range for each block in accordance with the determined results. Specifically, the operation determining unit 320 increases the irradiance of light with which a block having heavy discoloration is irradiated by, for example, raising the predetermined threshold for the block having heavy discoloration compared to the threshold for other blocks to increase the irradiation time for the block having heavy discoloration.
  • When the light emission control is changed depending on the skin conditions, a table that describes, for example, the information indicating the skin conditions, the irradiance for each color range, the threshold corresponding to the upper limit of rejuvenation of the skin for each color range, and the maximum irradiation time for each color range in association with one another has to be stored in advance in the information storage unit 310.
  • In the case where each skin-condition sensor includes a tone sensor, the operation determining unit 320 may reduce or stop emission of light applied to each block when the degree of change of the skin color has arrived at a predetermined threshold. This is because the skin color represents the state of blood circulation (darkening) of the skin, that is, the degree of rejuvenation of the skin.
  • In the case where each skin-condition sensor includes a tone sensor, the tone sensor may detect the skin tone using light emitted from light sources other than the light-emitting device units. This is because the tone sensor is not used for image capturing and thus reflected light obtained when ambient light such as illumination from a dresser is incident on and reflected off the skin is bright enough for use in the spectroscopic analysis. In this case, the sheet member 210 needs to allow light to pass therethrough.
  • Desirably, the tone sensor is disposed on the sheet device 200 in such a manner as not to come into contact with the skin so that the toner sensor can capture light reflected off the skin.
  • Fig. 9 illustrates an example of a cross section of the sheet device 200 including a tone sensor. Fig. 9 illustrates a portion of the entire sheet device 200.
  • As illustrated in Fig. 9, the light emission surface 231 of each light-emitting device 230 is positioned substantially flush with the surface 211 of the sheet member 210 that comes into close contact with the skin (the surface is hereinafter referred to as a "close contact surface"). On the other hand, the light receiving surface 221 of the skin-condition sensor 220 (tone sensor) is set back inward from the close contact surface 211 of the sheet member 210. For example, the light receiving surface 221 of the skin-condition sensor 220 is spaced apart from the skin by approximately 100 micrometers while the close contact surface 211 of the sheet member 210 is in close contact with the skin.
  • In the case where the skin-condition sensor 220 includes a tone sensor, the outputs from the light-emitting devices of different colors have to be balanced throughout the blocks so as to satisfy a predetermined balance. Thus, it is desirable that the operation determining unit 320 has a function of calibrating outputs from the light-emitting devices of different colors. The calibration is performed by, for example, adjusting outputs from the light-emitting devices so that the detection values from the tone sensor obtained when white paper is applied to the close contact surface 211 of the sheet member 210 approximate a predetermined value.
  • Besides the change of the blood flow or the skin color, the degree of rejuvenation of the skin is expressed in, for example, a change of the skin temperature. Thus, the phototherapeutic device 100 may include a temperature sensor as a skin-condition sensor and stop light emission in accordance with the change of the detected skin temperature. In this case, an example usable as a standard for determining a stop of light emission is an increase in temperature by one degree. It is desirable that the determination with respect to the temperature be made on the basis of the absolute values whereas the determination with respect to the blood flow be made on the basis of the relative values. An example usable as a temperature sensor is a temperature sensor in which an organic molecule layer of an organic thin film transistor is formed of a phthalocyanine nano-size structure (see, for example, International Publication No. 2013/151128 ).
  • The phototherapeutic device 100 may alternatively control light emission on the basis of both the change of blood flow and the change of the temperature. In this case, it is desirable that the phototherapeutic device 100 stop emission of light applied to eyelid portions when the degree of change of the temperature at the eyelid portions exceeds a predetermined threshold regardless of the degree of the change of blood flow to prevent the high temperature from imposing a load on the skin at the eyelid portions. The phototherapeutic device can have a high temperature due to a breakdown, whereby stopping light emission in response to such a temperature change also enhances the product safety.
  • At least one of the functions of the control unit 300 according to the second embodiment may be implemented by other devices having different functions, such as mobile phones.
  • At least one of the functions of the control unit 300 may be implemented by a network server. Specifically, at least one of the functions of the phototherapeutic device may be implemented by cloud computing. In this case, the operation determining unit needs to include at least a communication unit, transmit data of the skin conditions to the server, and obtain timing of stopping light emission.
  • A sheet that covers portions of the body other than the face is usable in the phototherapeutic device 100. In this case, for example, the use of the phototherapeutic device 100 can effectively reduce macular discoloration on the back due to a sunburn or other causes.
  • The phototherapeutic device 100 may have operation determining units 320 corresponding to different blocks, each of the operation determining units 320 performing operations for the corresponding block.
  • The phototherapeutic device of this disclosure includes a sheet member that is attachable to a skin; a skin-condition sensor that is disposed in the sheet member and that detects information related to a condition of the skin; and a light-emitting device unit that is disposed in the sheet member, the light-emitting device unit operating on the basis of the information detected by the skin-condition sensor, wherein the light-emitting device unit includes a plurality of light-emitting devices that emit light having different wavelengths.
  • In the phototherapeutic device, the light-emitting device unit may reduce or stop light emission when the degree to which the information detected by the skin-condition sensor changes arrives at a predetermined threshold after a start of the light emission.
  • In the phototherapeutic device, a plurality of skin-condition sensors may be disposed at different positions of the sheet member, each of the skin-condition sensors may detect information related to a condition of a portion of the skin, a plurality of light-emitting device units may be disposed at different positions of the sheet member, each of the light-emitting device units may be disposed at a position corresponding to at least one of the skin-condition sensors, each of the light-emitting device units may operate on the basis of the information detected by the at least one corresponding skin-condition sensor.
  • In the phototherapeutic device, the sheet member may be attached to a predetermined portion of a face, the light-emitting device unit may irradiate the skin with predetermined light that facilitates rejuvenation of the skin, the skin-condition sensor may detect at least one of a blood flow and a temperature of the skin as the information related to the condition, and the predetermined threshold may be determined for each of the light-emitting devices by using, as a reference, the condition of the skin before the information detected by the skin-condition sensor changes.
  • In the phototherapeutic device, the sheet member may include a first region corresponding to one eyelid portion of the face and a second region different from the first region, the plurality of light-emitting device units may include a second light-emitting device unit disposed in the first region and a third light-emitting device unit disposed in the second region, the second light-emitting device unit emits light having an intensity lower than an intensity of light emitted by the third light-emitting device unit, and a predetermined threshold for the second light-emitting device unit may be lower than a predetermined threshold for the third light-emitting device unit.
  • In the phototherapeutic device, each of the light-emitting device units may gradually reduce the intensity of light when stopping the light emission.
  • In the phototherapeutic, the sheet member may include a plurality of sections, at least one of the skin-condition sensors may be disposed in each of the sections, at least one of the light-emitting device units may be disposed in each of the sections, and the phototherapeutic device may include an operation determining unit that determines an operation of the at least one light-emitting device unit disposed in one section on the basis of information detected by the at least one skin-condition sensor disposed in said one section.
  • In the phototherapeutic device, the light-emitting device unit may include a blue light emitting device, the skin-condition sensor may detect a tone of the skin as the information related to the condition of the skin in a state where the blue light emitting device is emitting light, and the operation determining unit may determine an intensity of light that is to be emitted by the light-emitting device unit on the basis of the tone.
  • In the phototherapeutic device, the sheet member may be detachably connected to the operation determining unit using a connector and a cable.
  • A phototherapeutic method according to this disclosure include detecting information related to a condition of a skin using a skin-condition sensor disposed on a sheet member attachable to the skin; and operating a light-emitting device unit disposed in the sheet member on the basis of the information detected by the skin-condition sensor.
  • The disclosure is usable as a device such as a phototherapeutic device that can more effectively rejuvenate the skin.

Claims (6)

  1. A phototherapeutic device, comprising:
    a sheet member (200, 210) attachable to a skin;
    a plurality of skin-condition sensors (220, 2201-220M) disposed at different positions of the sheet member and each being configured to detect information related to a condition of a portion of the skin; and
    a plurality of light-emitting device units (500, 2301-230N) disposed at positions on the sheet member corresponding to the positions of the respective skin-condition sensors, and the light-emitting device units being configured to operate on the basis of the information detected by the corresponding skin-condition sensors,
    wherein each of the light-emitting device units includes a plurality of light-emitting devices (2301-230N) that are configured to emit light having different wavelengths,
    the sheet member (200, 210) includes a plurality of sections,
    at least one of the skin-condition sensors and at least one of the light-emitting device units are disposed in each of the sections,
    the phototherapeutic device further includes an operation determining unit (320) configured to determine an operation of the at least one light-emitting device unit disposed in one section on the basis of the information detected by the at least one skin-condition sensor disposed in said one section,
    each of the light-emitting device units (2301-230N) is configured to reduce or stop light emission when
    the degree to which the information detected by the corresponding skin-condition sensor changes exceeds a predetermined threshold after a start of the light emission,
    the sheet member (200, 210) includes a first region corresponding to one eyelid portion of a face and a second region different from the first region,
    one of the plurality of light-emitting device units is disposed in the first region and another of the plurality of light-emitting device units is disposed in the second region,
    the one of the plurality of light-emitting device units is configured to emit light having an intensity lower than an intensity of light emitted by the another of the plurality of light-emitting device units, and
    the predetermined threshold for the one of the plurality of light-emitting device units is lower than the predetermined threshold for the another of the plurality of light-emitting device units.
  2. The phototherapeutic device according to Claim 1,
    wherein the sheet member (200, 210) is configured to be attached to a predetermined portion of the face,
    wherein at least one of the light-emitting device units (500, 2301-230N) is configured to irradiate the skin
    with predetermined light that facilitates rejuvenation of the skin,
    wherein at least one of the skin-condition sensors (200, 2201-220M) is configured to detect at least one
    of a blood flow and a temperature of the skin as the information related to the condition, and
    wherein the predetermined threshold is determined for each of the light-emitting devices by using, as a reference, the condition of the skin before the information detected by the at least one of the skin-condition sensor changes.
  3. The phototherapeutic device according to Claim 1, wherein each of the light-emitting device units is configured to gradually reduce the intensity of light when stopping the light emission.
  4. The phototherapeutic device according to Claim 1,
    wherein each of the light-emitting device units (500, 2301-230N) includes a blue light emitting device,
    wherein at least one of the skin-condition sensors (220, 2201-220M) detects a tone of the skin as the information related to the condition in a state where the blue light emitting device is emitting light, and
    wherein the operation determining unit (320) determines an intensity of light that is to be emitted by the corresponding light-emitting device unit on the basis of the tone.
  5. The phototherapeutic device according to Claim 1, wherein the sheet member (200, 210) is detachably connected to the operation determining unit using a connector (401) and a cable (400).
  6. A phototherapeutic cosmetic method, comprising:
    detecting information related to a condition of a portion of skin using each of a plurality of skin-condition sensors (220, 2201-220M) disposed at different positions of a sheet member (200,210) that is attachable to the skin; and
    operating a plurality of light-emitting device units (500, 2301-230N) disposed at positions on the sheet member, corresponding to the positions of the respective skin-condition sensors, on the basis of information detected by the corresponding skin-condition sensors,
    wherein each of the light-emitting device units includes a plurality of light-emitting devices (2301-230N) that emit light having different wavelengths,
    the sheet member (200, 210) includes a plurality of sections,
    at least one of the skin-condition sensors and at least one of the light-emitting device units are disposed in each of the sections, and
    the method further comprising determining, using an operation determining unit (320) that, an operation of the at least one light-emitting device unit disposed in one section on the basis of the information detected by the at least one skin-condition sensor disposed in said one section,
    each of the light-emitting device units (2301-230N) reduces or stops light emission when the degree to which the information detected by the corresponding skin-condition sensor changes exceeds a predetermined threshold after a start of the light emission,
    the sheet member (200, 210) includes a first region corresponding to one eyelid portion of a face and a second region different from the first region,
    one of the plurality of light-emitting device units is disposed in the first region and another of the plurality of light-emitting device units is disposed in the second region,
    the one of the plurality of light-emitting device units emits light having an intensity lower than an intensity of light emitted by the another of the plurality of light-emitting device units, and
    the predetermined threshold for the one of the plurality of light-emitting device units is lower than the predetermined threshold for the another of the plurality of light-emitting device units.
EP14195822.3A 2013-12-27 2014-12-02 Phototherapeutic device and phototherapeutic method Not-in-force EP2889054B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013272326 2013-12-27

Publications (2)

Publication Number Publication Date
EP2889054A1 EP2889054A1 (en) 2015-07-01
EP2889054B1 true EP2889054B1 (en) 2017-10-11

Family

ID=52020978

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14195822.3A Not-in-force EP2889054B1 (en) 2013-12-27 2014-12-02 Phototherapeutic device and phototherapeutic method

Country Status (4)

Country Link
US (1) US9555261B2 (en)
EP (1) EP2889054B1 (en)
JP (1) JP2015142717A (en)
CN (1) CN104740785B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6443731B2 (en) * 2014-01-31 2018-12-26 パナソニックIpマネジメント株式会社 Tooth bleaching device and operating method of tooth bleaching device
JP2015164511A (en) * 2014-02-07 2015-09-17 パナソニックIpマネジメント株式会社 Hair growth inhibition apparatus and hair growth inhibition method
US10888708B2 (en) * 2015-11-11 2021-01-12 Qc, Llc Phototherapy device with real-time morphologic feedback and guidance
KR20180115212A (en) * 2016-03-11 2018-10-22 주식회사 넥스프레스 A skin attachment including a light-emitting element and a storage device therefor
JP6541638B2 (en) * 2016-12-28 2019-07-10 堺化学工業株式会社 Phosphor-containing multilayer film sheet and light emitting device
JP6334046B1 (en) * 2016-12-30 2018-05-30 有限会社スルガ機設 Nail resin curing device, light irradiation device
CA3076802A1 (en) * 2017-09-29 2019-04-04 Johnson & Johnson Consumer Inc. Diagnostic and treatment kit
FR3071743B1 (en) * 2017-10-02 2019-09-20 Danielle Roches COSMETIC FACIAL SKIN CARE TREATMENT DEVICE
JP2019099957A (en) * 2017-12-05 2019-06-24 孝子 椎原 Therapeutic method of eyelash extension
CN110090351B (en) * 2018-01-30 2020-11-10 京东方光科技有限公司 Wearable skin beauty device and wearable eye patch
US10935376B2 (en) 2018-03-30 2021-03-02 Koninklijke Philips N.V. System and method for 3D scanning
US11285335B2 (en) * 2018-10-08 2022-03-29 Biohacked, Inc. Photo-therapeutic method and apparatus
JP7220964B2 (en) 2018-10-26 2023-02-13 株式会社日本触媒 Organic electroluminescent sheet for photocosmetics or phototherapy
US11963433B2 (en) 2018-12-21 2024-04-16 The University Of Tokyo Organic electroluminescent element
KR102285202B1 (en) * 2019-09-24 2021-08-04 단국대학교 천안캠퍼스 산학협력단 Personalized mask device using electrical stimulation
KR102285201B1 (en) * 2019-09-24 2021-08-04 단국대학교 천안캠퍼스 산학협력단 Personalized mask device using chemical solution
KR102116334B1 (en) * 2019-09-24 2020-05-29 단국대학교 천안캠퍼스 산학협력단 Personalized mask device using multi-wavelength laser
KR102285203B1 (en) * 2019-09-24 2021-08-04 단국대학교 천안캠퍼스 산학협력단 Personalized mask device using ultrasonic wave
CN113081253A (en) * 2021-03-30 2021-07-09 北京美医医学技术研究院有限公司 Intelligent acne removing system based on infrared laser
CN114028725A (en) * 2021-09-28 2022-02-11 杭州领挚科技有限公司 QLED (quantum light emitting diode) light-emitting module and beauty instrument

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070129776A1 (en) * 2005-10-20 2007-06-07 Light Sciences Llc External wearable light therapy treatment systems
US20080269849A1 (en) * 2007-04-19 2008-10-30 Mergenet Medical, Inc. Temporal control in phototherapy

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596016B1 (en) * 1997-03-27 2003-07-22 The Board Of Trustees Of The Leland Stanford Junior University Phototherapy of jaundiced newborns using garments containing semiconductor light-emitting devices
US20050177093A1 (en) * 2002-03-04 2005-08-11 Barry Hart M. Joint / tissue inflammation therapy and monitoring device
WO2004043543A1 (en) * 2002-11-12 2004-05-27 Palomar Medical Technologies, Inc. Apparatus for performing optical dermatology
JP2005027702A (en) 2003-07-07 2005-02-03 Ya Man Ltd Face treatment mask
JP2008508985A (en) * 2004-08-09 2008-03-27 ルミポート エルエルシー Phototherapy device for skin treatment
GB2437768A (en) 2006-05-03 2007-11-07 Seiko Epson Corp Photosensing TFT
JP2009028267A (en) * 2007-07-26 2009-02-12 Panasonic Electric Works Co Ltd Light irradiating beauty instrument
JP2009028268A (en) * 2007-07-26 2009-02-12 Panasonic Electric Works Co Ltd Light irradiating beauty instrument
JP5079421B2 (en) 2007-08-17 2012-11-21 国立大学法人九州大学 Organic electroluminescence device and organic laser diode
WO2009072085A2 (en) 2007-12-06 2009-06-11 L'oreal Uses of electroactive material actuators in cosmetics
US8562659B2 (en) * 2008-12-30 2013-10-22 Koninklijke Philips N.V. System and method for administering light therapy
KR100963687B1 (en) * 2009-07-23 2010-06-15 김희구 Massage machine and method using the same
JP5483956B2 (en) 2009-08-21 2014-05-07 日立マクセル株式会社 Beauty equipment
JP2011067454A (en) 2009-09-25 2011-04-07 Panasonic Electric Works Co Ltd Light irradiation type cosmetic apparatus
WO2012011042A2 (en) * 2010-07-22 2012-01-26 Koninklijke Philips Electronics N.V. Improvements in phototherapy
TWI450742B (en) * 2011-03-15 2014-09-01 Crystalvue Medical Corp Optical apparatus
US8771328B2 (en) * 2011-09-08 2014-07-08 La Lumiere Llc Light therapy platform system
JP2013126485A (en) * 2011-12-19 2013-06-27 Panasonic Corp Light irradiation device
JP2013168575A (en) 2012-02-16 2013-08-29 Univ Of Tokyo Elastic circuit board
JP5338939B2 (en) 2012-04-06 2013-11-13 Dic株式会社 Phthalocyanine nano-sized structure and electronic device using the nano-sized structure
JP2013154229A (en) 2013-05-16 2013-08-15 Panasonic Corp Light irradiation cosmetic apparatus
US20150127072A1 (en) * 2013-11-07 2015-05-07 Espansione Marketing S.P.A. Device for emitting light by means of leds of the continuous and pulsed type for aesthetic and therapeutic treatments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070129776A1 (en) * 2005-10-20 2007-06-07 Light Sciences Llc External wearable light therapy treatment systems
US20080269849A1 (en) * 2007-04-19 2008-10-30 Mergenet Medical, Inc. Temporal control in phototherapy

Also Published As

Publication number Publication date
EP2889054A1 (en) 2015-07-01
US9555261B2 (en) 2017-01-31
CN104740785A (en) 2015-07-01
US20150182758A1 (en) 2015-07-02
CN104740785B (en) 2018-06-08
JP2015142717A (en) 2015-08-06

Similar Documents

Publication Publication Date Title
EP2889054B1 (en) Phototherapeutic device and phototherapeutic method
EP2889053B1 (en) Percutaneous penetration enhancing apparatus
EP2901999A1 (en) Massaging apparatus
CN107160865B (en) Image processing apparatus, printing apparatus, and image processing method
US20110184499A1 (en) Skin treatment device and system
KR101122679B1 (en) Mask having skin care and therapy function
US11975215B2 (en) Devices and related methods for phototherapeutic treatment of skin
KR102083650B1 (en) LED mask
CN107125904B (en) Image processing apparatus and image processing method
EP2905052A1 (en) Hair growth inhibition apparatus and hair growth inhibition method
KR102062605B1 (en) LED mask
US9622841B2 (en) Tooth whitening apparatus and tooth whitening method
KR20220024872A (en) Adjustable Therapeutic Face Mask
KR20200098926A (en) Smart Mirror, User Terminal, Skin Care System Comprising the same and Method thereof
WO2020040435A1 (en) Light therapeutic apparatus
CN109350013A (en) Equipment for skin-whitening beauty
EP2902000A1 (en) Gum massaging device
US20220339462A1 (en) A novel phototherapy face mask
KR20200137063A (en) Mask sheet provided with conductive pattern an mask device including the same
KR102539135B1 (en) Facial mask control module and light irradiation system
WO2024101365A1 (en) Skin treatment device
KR102157630B1 (en) Glass-Type Photocosmetic Device
WO2024101371A1 (en) Skin action device
CN118121848A (en) Phototherapy instrument and control method thereof
KR20200110509A (en) Skin beauty management device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20141202

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

R17P Request for examination filed (corrected)

Effective date: 20151214

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17Q First examination report despatched

Effective date: 20160831

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20170426

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 935503

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171115

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014015640

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 4

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20171011

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 935503

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180112

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180111

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180211

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014015640

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

26N No opposition filed

Effective date: 20180712

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171202

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171202

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20171231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20141202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20211222

Year of fee payment: 8

Ref country code: DE

Payment date: 20211210

Year of fee payment: 8

Ref country code: FR

Payment date: 20211224

Year of fee payment: 8

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602014015640

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20221202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221202

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221231